dopamine + lidocaine

Dopamine + lidocaine is an experimental combination of two well-established drugs, dopamine and lidocaine, investigated primarily for its potential synergistic effects in cutaneous analgesia. Dopamine is a catecholamine neurotransmitter and vasopressor used to treat hemodynamic imbalances such as shock, acting mainly through agonism at dopaminergic and adrenergic receptors to increase cardiac output and perfusion. Lidocaine is a local anesthetic and class Ib antiarrhythmic agent that works by blocking voltage-gated sodium channels in neuronal membranes, thereby inhibiting nerve impulse conduction to produce local anesthesia. Preclinical studies have shown that coadministration of dopamine with lidocaine produces a synergistic effect on cutaneous analgesia—dopamine alone can induce dose-dependent analgesia but when combined with lidocaine enhances the quality and duration of the anesthetic effect beyond either drug alone. This combination has not been approved for clinical use but has been studied in animal models as an infiltrative anesthetic approach.